IP Library Granted Patent US 7,700,363
Granted Patent B2
US 7,700,363 · App. 11/639,211 · Granted Apr 20, 2010

Method for screening crystallization conditions in solution crystal growth

Assignee: UAB Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,700,363
App. No.
11/639,211
Granted
Apr 20, 2010
Kind
B2
Abstract

A method of screening protein crystal growth conditions with picogram to microgram amounts of protein in picoliter or nanoliter volumes is provided. A preferred method comprises a microarray with a plurality of microchambers in the microarray. A protein solution is placed into the micro-chambers by an automated dispensing mechanism. The protein crystal growth conditions of each of the micro-chambers is adjusted so that the protein crystal growth conditions in at least two of the micro-chambers differs. Crystallization of the protein solution in the micro-chambers is effected. For example, crystallization can be effected by a precipitate solution and/or placing an oil barrier over the protein solution. Protein crystal growth in the micro-chambers is then observed.

Claims (20)

1. A method of screening protein crystal growth conditions comprising:

dispensing a protein solution into protein solution microchambers of a microarray and separately dispensing precipitate solutions into precipitate solution microchambers of said microarray, said microchambers having a volume from about 0.001 nl to about 500 nl;

allowing liquid-liquid communication between protein solution microchambers and precipitate solution microchambers; and

observing said microchambers for protein crystal growth or protein precipitation.

2. The method of claim 1 wherein said precipitate solution comprises a component selected from the group consisting of buffers, surface active agents, salts, alcohols, polyethylene glycol and mixtures thereof.

3. The method of claim 1 wherein said protein solution is buffered.

4. The method of claim 1 wherein said microarray comprises valves between protein solution microchambers and precipitate solution microchambers.

5. The method of claim 4 wherein said valves control and liquid-liquid communication between microchambers comprising protein solution and a microchambers comprising a precipitate solution.

6. The method of claim 5 wherein controlling protein crystal growth further comprises employing microchambers of varying dimensions.

7. The method of claim 1 wherein said precipitate solution and said protein solution are in fluid communication via micro-channels.

8. The method of claim 4 wherein said precipitate solution and said protein solution are in fluid communication via a channel.

9. The method of claim 5 wherein said allowing liquid-liquid communication of said precipitate solution microchambers and said protein solution microchambers comprises opening said valves.

10. A method of screening protein crystal growth conditions comprising:

transferring samples comprising a volume from about 0.001 nl to about 500 nl of a protein solution into microchambers in a platform;

providing a precipitate solution that is in liquid-liquid communication with the protein solution;

controlling the protein crystal growth conditions of the samples; and observing a protein precipitate or protein crystals in the microchambers.

11. The method of claim 10 wherein controlling the protein crystal growth condition comprises employing a valve disposed in a microchannel between a microchamber comprising protein solution and a microchamber comprising precipitate solution.

12. The method of claim 1 wherein said microarray comprises miniaturized active control elements between protein solution microchambers and precipitate solution microchambers.

13. The method of claim 12 wherein the platform is a microarray.

14. The method of claim 12 wherein the miniaturized active control elements are selected from the group consisting of valves, pumps, and electrodes.

Assignments (1)
SECURITY INTEREST Recorded Dec 19, 2017
From: CYTOBIOSCIENCE, INC.
To: CLEMENTS, IAN
Reel/Frame 044435/0115 →
Continuity (4)
Division 0994766500 · Sep 6, 2001
Continuation In Part 0954332600 · Apr 5, 2000
Provisional Application 6012801800 · Apr 6, 1999
Related Publication 20070202602A1 · Aug 30, 2007